Stock BIOS BIOSENIC SA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BioSenic SA

Equities

BIOS

BE0974280126

Market Closed - Euronext Bruxelles
Other stock markets
 11:22:18 2024-07-03 am EDT 		5-day change 1st Jan Change
0.0151 EUR -10.65% Intraday chart for BioSenic SA -15.64% -75.33%
Jul. 02 BioSenic, Phebra Update Licensing Terms for Oral Arsenic Trioxide Drug Development MT
Jul. 02 BioSenic and Medsenic SAS Sign New Set of Licensing and Commercialization Agreements with Phebra Pty Ltd CI

Evolution of the average Target Price on BioSenic SA

Price target over the last 5 years

History of analyst recommendation changes

bd875b78956a9191cb7.cny5V0f29UJUngyDYk9SQdYU_YjBMNtQv1To3iGtawY.PDHQBiSpmDEa0UnuCHgZE4Z_t7uEBbcT8hayrlDUXW8eOo8yNp3GFxX4Yw~bdb1b21824e6df0610a4ce79646fc190

Analyst Recommendations on BioSenic SA

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron... Our Logo
Bone Therapeutics Allogeneic Cell Therapy Product, ALLOB, Shows 90% Fusion Rate at 24 Months in Phase IIa Study in Lumbar Spinal Fusion CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.0151 EUR
Average target price
0.1 EUR
Spread / Average Target
+562.25%
High Price Target
0.1 EUR
Spread / Highest target
+562.25%
Low Price Target
0.1 EUR
Spread / Lowest Target
+562.25%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BIOS Stock
  4. Consensus BioSenic SA